Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:918-923
Published online before print March 15, 2004, doi: 10.1161/01.HYP.0000124670.03674.15
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/5/918    most recent
01.HYP.0000124670.03674.15v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reckelhoff, J. F.
Right arrow Articles by Fortepiani, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reckelhoff, J. F.
Right arrow Articles by Fortepiani, L. A.
Related Collections
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies

(Hypertension. 2004;43:918.)
© 2004 American Heart Association, Inc.


Brief Reviews

Novel Mechanisms Responsible for Postmenopausal Hypertension

Jane F. Reckelhoff; Lourdes A. Fortepiani

From the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson.

Correspondence to Dr Jane F. Reckelhoff, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS 39216. E-mail jreckelhoff{at}physiology.umsmed.edu

Blood pressure increases in many women after menopause. Hypertension is one of the major risk factors for cardiovascular disease. However, the mechanisms responsible for the postmenopausal increase in blood pressure are yet to be elucidated. Various humoral systems have been proposed to play a role in postmenopausal hypertension, such as changes in estrogen/androgen ratios, increases in endothelin and oxidative stress, and activation of the renin-angiotensin system (RAS). In addition, obesity, type II diabetes, and activation of the sympathetic nervous system are common in postmenopausal women and may also play important roles. However, progress in elucidating the mechanisms responsible for postmenopausal hypertension has been hampered by the lack of a suitable animal model. The aging female spontaneously hypertensive rat (SHR) exhibits many of the characteristics found in postmenopausal women. In this review, some of the possible mechanisms that could play a role in postmenopausal hypertension are discussed, as well as the characteristics of the aged female SHR as a model to study.


Key Words: endothelin • renin-angiotensin system • oxidative stress • obesity • diabetes mellitus • sympathetic nervous system




This article has been cited by other articles:


Home page
Eur Respir JHome page
J. Aittokallio, T. Saaresranta, A. Virkki, N. Karppinen, O. J. Heinonen, T. Aittokallio, and O. Polo
Transcutaneous carbon dioxide profile during sleep reveals metabolic risk factors in post-menopausal females
Eur. Respir. J., November 1, 2009; 34(5): 1132 - 1139.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. A. Graham and J. W. E. Rush
Cyclooxygenase and thromboxane/prostaglandin receptor contribute to aortic endothelium-dependent dysfunction in aging female spontaneously hypertensive rats
J Appl Physiol, October 1, 2009; 107(4): 1059 - 1067.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Mayan, S. Melnikov, I. Novikov, E. J. Holtzman, and Z. Farfel
Familial Hyperkalemia and Hypertension: Pathogenetic Insights Based on Lithium Clearance
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3010 - 3016.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. A. Georgiopoulos, K. S. Stamatelopoulos, I. Lambrinoudaki, M. Lykka, K. Kyrkou, D. Rizos, M. Creatsa, G. Christodoulakos, M. Alevizaki, P. P. Sfikakis, et al.
Prolactin and Preclinical Atherosclerosis in Menopausal Women With Cardiovascular Risk Factors
Hypertension, July 1, 2009; 54(1): 98 - 105.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. K. Goldman, A. S. Azar, J. M. Mulvaney, C. Hinojosa-Laborde, J. R. Haywood, and V. L. Brooks
Baroreflex sensitivity varies during the rat estrous cycle: role of gonadal steroids
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1419 - R1426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Ebrahimian, M. R. Sairam, E. L. Schiffrin, and R. M. Touyz
Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1481 - H1488.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Pendergrass, N. T. Pirro, B. M. Westwood, C. M. Ferrario, K. B. Brosnihan, and M. C. Chappell
Sex differences in circulating and renal angiotensins of hypertensive mRen(2).Lewis but not normotensive Lewis rats
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H10 - H20.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
L. M Ritland, D L. Alekel, O. A Matvienko, K. B Hanson, J. W Stewart, L. N Hanson, M. B Reddy, M. D Van Loan, and U. Genschel
Centrally located body fat is related to appetitive hormones in healthy postmenopausal women.
Eur. J. Endocrinol., June 1, 2008; 158(6): 889 - 897.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G.-C. M. Gast, D. E. Grobbee, V. J.M. Pop, J. J. Keyzer, C. J.M. Wijnands-van Gent, G. N. Samsioe, P. M. Nilsson, and Y. T. van der Schouw
Menopausal Complaints Are Associated With Cardiovascular Risk Factors
Hypertension, June 1, 2008; 51(6): 1492 - 1498.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. E. Hall, J. P. Granger, J. F. Reckelhoff, and K. Sandberg
Hypertension and Cardiovascular Disease in Women
Hypertension, April 1, 2008; 51(4): 951 - 951.
[Full Text] [PDF]


Home page
HypertensionHome page
M. Coylewright, J. F. Reckelhoff, and P. Ouyang
Menopause and Hypertension: An Age-Old Debate
Hypertension, April 1, 2008; 51(4): 952 - 959.
[Full Text] [PDF]


Home page
HypertensionHome page
L. L. Yanes, J. C. Sartori-Valinotti, and J. F. Reckelhoff
Sex Steroids and Renal Disease: Lessons From Animal Studies
Hypertension, April 1, 2008; 51(4): 976 - 981.
[Full Text] [PDF]


Home page
Eur Heart JHome page
P. Collins, G. Rosano, C. Casey, C. Daly, M. Gambacciani, P. Hadji, R. Kaaja, T. Mikkola, S. Palacios, R. Preston, et al.
Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists
Eur. Heart J., August 2, 2007; 28(16): 2028 - 2040.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. R. Ferreri
Estrogen-TNF interactions and vascular inflammation
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2566 - H2569.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. L. Rogers, A. R. Mitchell, C. Maric, K. Sandberg, A. Myers, and S. E. Mulroney
Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R794 - R799.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. Jazbutyte, K. Hu, P. Kruchten, E. Bey, S. K.G. Maier, K.-H. Fritzemeier, K. Prelle, C. Hegele-Hartung, R. W. Hartmann, L. Neyses, et al.
Aging Reduces the Efficacy of Estrogen Substitution to Attenuate Cardiac Hypertrophy in Female Spontaneously Hypertensive Rats
Hypertension, October 1, 2006; 48(4): 579 - 586.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. A. Arenas, S. J. Armstrong, Y. Xu, and S. T. Davidge
Tumor Necrosis Factor-{alpha} and Vascular Angiotensin II in Estrogen-Deficient Rats
Hypertension, September 1, 2006; 48(3): 497 - 503.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. F. Reckelhoff
Cardiovascular Disease, Estrogen Deficiency, and Inflammatory Cytokines
Hypertension, September 1, 2006; 48(3): 372 - 373.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. L. Yanes, D. G. Romero, J. W. Iles, R. Iliescu, C. Gomez-Sanchez, and J. F. Reckelhoff
Sexual dimorphism in the renin-angiotensin system in aging spontaneously hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R383 - R390.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. A. Khalil
Sex Hormones as Potential Modulators of Vascular Function in Hypertension
Hypertension, August 1, 2005; 46(2): 249 - 254.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. K. Dubey, B. Imthurn, M. Barton, and E. K. Jackson
Vascular consequences of menopause and hormone therapy: Importance of timing of treatment and type of estrogen
Cardiovasc Res, May 1, 2005; 66(2): 295 - 306.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. M. Pollock
Endothelin, Angiotensin, and Oxidative Stress in Hypertension
Hypertension, April 1, 2005; 45(4): 477 - 480.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose
Functional genomics of the dopaminergic system in hypertension
Physiol Genomics, November 17, 2004; 19(3): 233 - 246.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. M. Harrison-Bernard
Targeting of the Renin-Angiotensin System as an Adjunct to Estrogen Replacement Therapy
Hypertension, October 1, 2004; 44(4): 390 - 391.
[Full Text] [PDF]